The Clinical Services Journal’s editor Chris Shaw recently visited Unisurge’s Newmarket headquarters to discover the latest expansion developments, and to find out more about the procedure pack specialist’s commitment to delivering quality items at a competitive price.
Established in 2005, Unisurge has since achieved exceptional growth and, while many organisations may fear the consequences of Brexit, Phil Crook, director of sales, Unisurge International, believes the company is more than equipped to deal with any issues. To facilitate future business opportunities, Unisurge has invested in a £6 million expansion project at its Newmarket headquarters.
“Brexit may create import issues, however Unisurge are prepared for any challenges,” said Phil. “For example, we bring in the majority of our items from the Far East; we buy in bulk and we hold stock, Unisurge have 12 weeks’ worth of raw materials and finished goods on the shelf at any given time.
“From a development point of view, everything that we build is built in our own cleanrooms. It goes through sterilisation in our onsite ETO’s, it’s stored in one of our three warehouses and it’s delivered across the whole of the UK using our own vehicles. Brexit won’t have the same impact on Unisurge – because we are UK based and UK focused.”
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
